ZA965482B - Novel antigen. - Google Patents
Novel antigen.Info
- Publication number
- ZA965482B ZA965482B ZA9605482A ZA965482A ZA965482B ZA 965482 B ZA965482 B ZA 965482B ZA 9605482 A ZA9605482 A ZA 9605482A ZA 965482 A ZA965482 A ZA 965482A ZA 965482 B ZA965482 B ZA 965482B
- Authority
- ZA
- South Africa
- Prior art keywords
- methods
- influenzae
- protein
- novel antigen
- rerspiratory
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 238000000034 method Methods 0.000 abstract 4
- 241000606768 Haemophilus influenzae Species 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 206010033078 Otitis media Diseases 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9513074.6A GB9513074D0 (en) | 1995-06-27 | 1995-06-27 | Novel anigen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA965482B true ZA965482B (en) | 1997-12-29 |
Family
ID=10776746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9605482A ZA965482B (en) | 1995-06-27 | 1996-06-27 | Novel antigen. |
Country Status (18)
| Country | Link |
|---|---|
| US (4) | US6245338B1 (ja) |
| EP (1) | EP0835313B1 (ja) |
| JP (2) | JPH11510373A (ja) |
| KR (1) | KR19990028423A (ja) |
| CN (1) | CN1144875C (ja) |
| AT (1) | ATE317013T1 (ja) |
| AU (1) | AU708061B2 (ja) |
| CA (1) | CA2225405A1 (ja) |
| DE (1) | DE69635783T2 (ja) |
| ES (1) | ES2259443T3 (ja) |
| GB (1) | GB9513074D0 (ja) |
| MX (1) | MX9710412A (ja) |
| NO (1) | NO976119L (ja) |
| NZ (1) | NZ311120A (ja) |
| RU (1) | RU2221045C2 (ja) |
| TW (1) | TW457247B (ja) |
| WO (1) | WO1997001638A1 (ja) |
| ZA (1) | ZA965482B (ja) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6468765B1 (en) | 1995-04-21 | 2002-10-22 | Human Genome Sciences, Inc. | Selected Haemophilus influenzae Rd polynucleotides and polypeptides |
| US6355450B1 (en) | 1995-04-21 | 2002-03-12 | Human Genome Sciences, Inc. | Computer readable genomic sequence of Haemophilus influenzae Rd, fragments thereof, and uses thereof |
| GB9904183D0 (en) * | 1999-02-24 | 1999-04-14 | Smithkline Beecham Biolog | Novel compounds |
| HU228499B1 (en) | 1999-03-19 | 2013-03-28 | Smithkline Beecham Biolog | Streptococcus vaccine |
| GB0022742D0 (en) | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
| US20040171802A1 (en) * | 2000-10-02 | 2004-09-02 | Josee Hamel | Haemophilus influenzae antigens and corresponding dna fragments |
| GB0103171D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| JP4740738B2 (ja) | 2002-08-02 | 2011-08-03 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
| WO2006110413A2 (en) * | 2005-03-30 | 2006-10-19 | Novartis Vaccines And Diagnostics Inc. | Haemophilus influenzae type b |
| CN100357318C (zh) * | 2005-10-11 | 2007-12-26 | 中山大学 | 美人鱼发光杆菌外膜蛋白w和编码序列及其制备方法和应用 |
| KR100743604B1 (ko) * | 2005-12-05 | 2007-07-27 | 볼보 컨스트럭션 이키프먼트 홀딩 스웨덴 에이비 | 차량용 머플러 구조 |
| TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
| GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
| EP3020411A1 (en) | 2005-12-22 | 2016-05-18 | GlaxoSmithKline Biologicals s.a. | Vaccine |
| UA92782C2 (ru) | 2006-01-17 | 2010-12-10 | Арне Форсгрен | Новый поверхностный белок haemophilus influenzae (белок е; ре) |
| PT2167121E (pt) | 2007-06-26 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vacina compreendendo conjugados de polissacáridos capsulares de streptococcus pneumoniae |
| GB201003924D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| GB201003922D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Conjugation process |
| BR112012022688A2 (pt) | 2010-03-10 | 2018-05-22 | Glaxosmithkline Biologicals Sa | proteína de fusão, vesícula da membrana externa isolada, polinucleotídeo, composição farmacêutica, vacina, método para tratamento ou prevenção de infecção ou doença por neisseria, uso e método para fabricar uma proteína de fusão |
| GB201103836D0 (en) | 2011-03-07 | 2011-04-20 | Glaxosmithkline Biolog Sa | Conjugation process |
| EP2717909B1 (en) | 2011-06-04 | 2017-12-06 | Rochester General Hospital Research Institute | Compositions and methods related to p6 of haemophilus influenzae |
| CA2871520C (en) * | 2012-04-26 | 2020-12-29 | Novartis Ag | Antigens from non-typeable h. influenzae |
| CN104370997B (zh) * | 2014-09-24 | 2018-07-31 | 陈辉 | 去除生物制品中细菌内毒素的试剂盒、方法及其生物制品的制备方法 |
| GB201518684D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
| GB201621686D0 (en) | 2016-12-20 | 2017-02-01 | Glaxosmithkline Biologicals Sa | Novel methods for inducing an immune response |
| US12016919B2 (en) | 2017-05-30 | 2024-06-25 | Glaxosmithkline Biologicals Sa | Methods for manufacturing an adjuvant |
| CA3083078A1 (en) | 2017-12-01 | 2019-06-06 | Glaxosmithkline Biologicals Sa | Saponin purification |
| US20210283238A1 (en) | 2018-08-07 | 2021-09-16 | Glaxosmithkline Biologicals Sa | Novel processes and vaccines |
| EP3886901A1 (en) | 2018-11-29 | 2021-10-06 | GlaxoSmithKline Biologicals S.A. | Methods for manufacturing an adjuvant |
| JP2022535091A (ja) | 2019-06-05 | 2022-08-04 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | サポニン精製 |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| GB202205833D0 (en) | 2022-04-21 | 2022-06-08 | Glaxosmithkline Biologicals Sa | Bacteriophage |
| WO2024017827A1 (en) | 2022-07-19 | 2024-01-25 | Glaxosmithkline Biologicals Sa | Continuous process for vaccine production |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE110965T1 (de) * | 1989-03-09 | 1994-09-15 | Praxis Biolog Inc | Impfstoffe gegen hämophilus influenzae. |
| GB9224584D0 (en) * | 1992-11-23 | 1993-01-13 | Connaught Lab | Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases |
-
1995
- 1995-06-27 GB GBGB9513074.6A patent/GB9513074D0/en active Pending
-
1996
- 1996-06-27 AT AT96920996T patent/ATE317013T1/de not_active IP Right Cessation
- 1996-06-27 ZA ZA9605482A patent/ZA965482B/xx unknown
- 1996-06-27 JP JP9504247A patent/JPH11510373A/ja active Pending
- 1996-06-27 AU AU62363/96A patent/AU708061B2/en not_active Ceased
- 1996-06-27 EP EP96920996A patent/EP0835313B1/en not_active Expired - Lifetime
- 1996-06-27 NZ NZ311120A patent/NZ311120A/en not_active IP Right Cessation
- 1996-06-27 CA CA002225405A patent/CA2225405A1/en not_active Abandoned
- 1996-06-27 CN CNB961951389A patent/CN1144875C/zh not_active Expired - Fee Related
- 1996-06-27 WO PCT/GB1996/001549 patent/WO1997001638A1/en active IP Right Grant
- 1996-06-27 ES ES96920996T patent/ES2259443T3/es not_active Expired - Lifetime
- 1996-06-27 RU RU98101249/13A patent/RU2221045C2/ru not_active IP Right Cessation
- 1996-06-27 DE DE69635783T patent/DE69635783T2/de not_active Expired - Lifetime
- 1996-06-27 KR KR1019970709739A patent/KR19990028423A/ko not_active Application Discontinuation
- 1996-09-12 TW TW085111139A patent/TW457247B/zh not_active IP Right Cessation
-
1997
- 1997-12-18 MX MX9710412A patent/MX9710412A/es not_active IP Right Cessation
- 1997-12-22 US US08/996,408 patent/US6245338B1/en not_active Expired - Fee Related
- 1997-12-29 NO NO976119A patent/NO976119L/no not_active Application Discontinuation
-
1999
- 1999-05-13 US US09/310,845 patent/US6284477B1/en not_active Expired - Fee Related
- 1999-05-13 US US09/310,847 patent/US6254875B1/en not_active Expired - Fee Related
-
2000
- 2000-04-12 US US09/548,023 patent/US6313281B1/en not_active Expired - Fee Related
-
2008
- 2008-09-03 JP JP2008226372A patent/JP2009034107A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997001638A1 (en) | 1997-01-16 |
| EP0835313B1 (en) | 2006-02-01 |
| AU6236396A (en) | 1997-01-30 |
| CN1189186A (zh) | 1998-07-29 |
| US6245338B1 (en) | 2001-06-12 |
| NO976119D0 (no) | 1997-12-29 |
| TW457247B (en) | 2001-10-01 |
| NZ311120A (en) | 1999-10-28 |
| JP2009034107A (ja) | 2009-02-19 |
| US6284477B1 (en) | 2001-09-04 |
| KR19990028423A (ko) | 1999-04-15 |
| AU708061B2 (en) | 1999-07-29 |
| DE69635783T2 (de) | 2006-11-02 |
| RU2221045C2 (ru) | 2004-01-10 |
| NO976119L (no) | 1998-02-26 |
| US6254875B1 (en) | 2001-07-03 |
| MX9710412A (es) | 1998-07-31 |
| ES2259443T3 (es) | 2006-10-01 |
| US6313281B1 (en) | 2001-11-06 |
| CN1144875C (zh) | 2004-04-07 |
| ATE317013T1 (de) | 2006-02-15 |
| CA2225405A1 (en) | 1997-01-16 |
| EP0835313A1 (en) | 1998-04-15 |
| GB9513074D0 (en) | 1995-08-30 |
| DE69635783D1 (de) | 2006-04-13 |
| JPH11510373A (ja) | 1999-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA965482B (en) | Novel antigen. | |
| WO2000039299A3 (en) | Streptococcus antigens | |
| WO1999042588A3 (en) | Group b streptococcus antigens | |
| NO980883D0 (no) | Forbindelser og fremgangsmåter for immunterapi og diagnose av tuberkulose | |
| EP2168596A3 (en) | Immunisation against chlamydia trachomatis | |
| HUP0302965A2 (hu) | Vakcina | |
| WO1998008542A3 (en) | Compounds and methods for treatment and diagnosis of mycobacterial infections | |
| GEP20022695B (en) | Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence and Uses Thereof | |
| WO2001098460A3 (en) | Fusion proteins of mycobacterium tuberculosis | |
| WO2002034773A3 (en) | Streptococcal genes | |
| HUP0204176A2 (hu) | PRRSV rekombináns virulencia gyengítése | |
| AU2667600A (en) | Identification of specific differentially expressed antigens | |
| HUP0200162A2 (hu) | Haemophilus somnus transzferrin-kötő fehérjék klónozása és expresszálása | |
| GB9502899D0 (en) | Novel antigen | |
| WO1999002554A3 (en) | Human herpesvirus-7 diagnostic and immunologic reagents and use thereof | |
| EP1950302A3 (en) | Streptococcus antigens |